1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,738 | 1,790 | 26.07. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.06. | Nanoform Finland Plc - Manager's Transactions - Miguel Calado | 1 | Cision News | ||
| 14.06. | Nanoform Finland Plc - Manager's Transactions - Albert Hæggström | 1 | Cision News | ||
| 14.06. | Share subscriptions based on the resolution by Nanoform Finland Plc's Annual General Meeting 2024 on remuneration of the Board of Directors | 1 | Cision News | ||
| 14.06. | Nanoform Finland Plc - Manager's Transactions - Mads Laustsen | 1 | Cision News | ||
| 14.06. | Nanoform Finland Plc - Manager's Transactions - Jeanne Thoma | 1 | Cision News | ||
| 30.05. | Nanoform's biologics technology showcased by large pharma at drug delivery conference; Nanoenzalutamide and nanoapalutamide partnering discussions progress as planned | 366 | PR Newswire | HELSINKI, May 30, 2024 /PRNewswire/ -- Manufacturing of GMP material in Project Nanoenzalutamide commenced. EU/US pivotal studies are planned to start in 4Q24, with the read-out in 1Q25.... ► Artikel lesen | |
| 29.05. | NANOFORM: Disclosure of Major Holdings under Law 163/2024 | 1 | Cision News | ||
| 16.05. | Invitation to Nanoform's Q1 2024 Report Presentation | 2 | Cision News | ||
| 26.04. | NANOFORM: Disclosure of Major Holdings under Law 163/2024 | 3 | Cision News | ||
| 25.04. | New shares of Nanoform registered with the trade register | 2 | Cision News | ||
| 24.04. | Nanoform successfully completes new share issue raising EUR 15.4 million to invest in commercialization of nanoparticle enabled formulations for next generation medicines | 2 | Cision News | ||
| 24.04. | Nanoform announces its intention to carry out a new share issue of approximately 7 million new shares to invest in commercialization of nanoparticle enabled formulations for next generation medicines | 5 | Cision News | ||
| 16.04. | Resolutions of Nanoform Finland Plc's Annual General Meeting on April 16, 2024 | 3 | Cision News | ||
| 16.04. | Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc | 1 | Cision News | ||
| 09.04. | Nanoform and PlusVitech partner to repurpose aprepitant as a treatment for lung cancer | 547 | PR Newswire | Nanoform Finland Plc
April 9, 2024
09.00 EEST / 08.00 CEST
HELSINKI, April 9, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company... ► Artikel lesen | |
| 26.03. | The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key individuals | 1 | Cision News | ||
| 12.03. | Notice to the Annual General Meeting of NANOFORM FINLAND Plc | 2 | Cision News | ||
| 12.03. | Share subscriptions based on Nanoform Finland Plc's stock options 2/2019 and 1/2020 | 1 | Cision News | ||
| 06.03. | Nanoform Finland Plc - Manager's transactions - Jeanne Thoma | 1 | Cision News | ||
| 06.03. | Nanoform Finland Plc - Manager's transactions - Albert Hæggström | 2 | Cision News |
Seite:
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 51,90 | +5,06 % | Formycon erwartet EU-Zulassung für FYB202 noch 2024 | Zu Formycons Stelara-Biosimilarkandidaten gibt es Neuigkeiten: FYB202 habe eine positive Empfehlung für die Marktzulassung vom Ausschuss für Humanarzneimittel der EMA erhalten. Die Europäische Kommission... ► Artikel lesen | |
| GAUZY | 10,380 | +8,01 % | Gauzy Ltd. Announces Preliminary Revenue Ranges, Demonstrating Strong Double-Digit Growth for the Second Quarter and First Half 2024 that Exceeded Expectations | TEL AVIV, Israel, July 15, 2024 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control solutions, today provided preliminary unaudited... ► Artikel lesen | |
| ACACIA RESEARCH | 5,250 | +7,14 % | Acacia Research Reports First Quarter 2024 Financial Results | NEW YORK--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG) ("Acacia" or the "Company") today reported financial results for the three months ended March 31, 2024.
Martin ("MJ") D.... ► Artikel lesen | |
| NVE | 77,00 | -1,91 % | Earnings call: NVE Corporation weathers semiconductor downturn | ||
| KOPIN | 1,009 | +1,92 % | Kopin Corporation: Kopin Expands Medical Offerings to Include Spatial Light Modulator That Enable Super-Resolution Microscopes | Ferroelectric LCOS modulators advance open-source research at top Medical, Biomedical and Research Institutions
Kopin Corporation (NASDAQ: KOPN), a leader in cutting-edge high-performance application-specific... ► Artikel lesen | |
| FENDX TECHNOLOGIES | 0,158 | -2,48 % | FendX Technologies Inc.: FendX Completes Successful Pilot Scale-Up Run of REPELWRAP Film with Dunmore | Oakville, Ontario--(Newsfile Corp. - July 24, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX") a nanotechnology company developing surface protection... ► Artikel lesen | |
| VEECO INSTRUMENTS | 36,000 | -1,10 % | Veeco Instruments Inc.: Veeco Reports Fourth Quarter and Fiscal Year 2023 Financial Results | Fourth Quarter 2023 Highlights: Revenue of $173.9 million, compared with $153.8 million in the same period last yearGAAP net income of $21.6 million, or $0.37 per diluted share, compared with $128.9... ► Artikel lesen | |
| XTPL | 24,350 | -5,07 % | EQS-News: XTPL S.A.: XTPL achieves PLN 5.5 million of commercial sales in H1 2024, two industrial modules delivered to clients | Issuer: XTPL S.A.
/ Key word(s): Preliminary Results/Sales Result
XTPL achieves PLN 5.5 million of commercial sales in H1 2024, two industrial modules delivered to clients
18.07.2024... ► Artikel lesen | |
| ONTO INNOVATION | 177,00 | +1,72 % | (ONTO) - Analyzing Onto Innovation's Short Interest | ||
| ADVANCE ZINCTEK | 0,432 | -1,82 % | ADVANCE ZINCTEK LIMITED: FY24 Loss Before Tax | ||
| NANOFOCUS | 1,250 | 0,00 % | EQS-Adhoc: NanoFocus AG: Ergänzungsverlangen zur Tagesordnung der ordentlichen Hauptversammlung am 28. August 2024 | EQS-Ad-hoc: NanoFocus AG / Schlagwort(e): Hauptversammlung
NanoFocus AG: Ergänzungsverlangen zur Tagesordnung der ordentlichen Hauptversammlung am 28. August 2024
25.07.2024 / 19:27 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| NANOVIRICIDES | 2,080 | +0,97 % | COVID is Here to Stay and NV-387 is a Much Needed Drug Against It, Reminds NanoViricides | SHELTON, CT / ACCESSWIRE / July 24, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today reminds the strong... ► Artikel lesen | |
| LEHNER INVESTMENTS | 0,013 | 0,00 % | EQS-DD: LEHNER INVESTMENTS AG: RIMIVY LTD, Verkauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
05.07.2024 / 16:36... ► Artikel lesen | |
| RIBER | 2,470 | 0,00 % | Riber's first-half revenue up 13% year-on-year to €13.7m | ||
| ZENTEK | 0,875 | -6,42 % | Zentek Launches National Sampling Program for ZenGUARD Antimicrobial Surgical Masks | GUELPH, ON / ACCESSWIRE / July 24, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company announces that it will embark... ► Artikel lesen |
Das Unternehmen NANOFORM FINLAND OYJ kann der Branche Nanotechnologie zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,012 (-0,69 %) liegt der Kurs bei 1,736 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NANOFORM FINLAND OYJ finden Sie auf Wallstreet Online.
